首页|阳性淋巴结比率对M0期非小细胞肺癌患者的预后影响

阳性淋巴结比率对M0期非小细胞肺癌患者的预后影响

扫码查看
目的 研究阳性淋巴结比率对M0期非小细胞肺癌的预后影响。方法 分析2010-2015年间SEER数据库中M0期非小细胞肺癌患者的临床数据,应用X-file软件选取阳性淋巴结比率的最佳截断值,运用Cox回归比例风险模型探讨阳性淋巴结比率在M。期非小细胞肺癌患者中的预后价值,Kaplan-Meier法绘制生存曲线分析两组的生存情况。结果 从数据库中提取37 001例M。期非小细胞肺癌患者的数据,X-file筛选出阳性淋巴结比率的最佳截断值为阳性淋巴结比率≤0。07和阳性淋巴结比率>0。07,通过Cox回归比例风险模型得到年龄、性别、人种、T分期、N分期、Grade分级、诊断到治疗的时间(月)、收入、肿瘤大小、肿瘤所在肺叶、有无系统治疗是同时影响M0期非小细胞肺癌患者总体生存期和肿瘤特异性生存期的独立风险因素,Kaplan-Meier生存曲线显示阳性淋巴结比率≤0。07组的预后要明显优于阳性淋巴结比率>0。07组(P<0。05)。结论 阳性淋巴结比率>0。07是M0期非小细胞肺癌患者预后的独立危险因素,预后预测价值高。
Effect of positive lymph node ratio on the prognosis of patients with M0 stage non-small cell lung cancer
Objective To investigate the effect of positive lymph node ratio on the prognosis of M0 stage non-small cell lung cancer.Methods The clinical data of patients with M0 stage non-small cell lung cancer in SEER data-base from 2010 to 2015 were analyzed.The best cut-off point of positive lymph node ratio was selected by X-file software.Univariate and multivariate Cox proportional hazard models were used to explore the prognostic value of positive lymph node ratio in patients with M0 stage non-small cell lung cancer.Kaplan-Meier method was used to draw survival curve to analyze the survival of the two groups.Result The data of 37 001 patients with M0 stage non-small cell lung cancer was extracted from the database.The best cut-off points of positive lymph node ratio selected by X-file were positive lymph node ratio≤0.07 and positive lymph node ratio>0.07.Age,sex,race,T stage,N stage,Grade stage,time from diagnosis to treatment(month),income,tumor size,lung lobe and systemic treat-ment were independent risk factors affecting overall survival and cancer specific survival of patients with M0 stage non-small cell lung cancer by Cox proportional hazard regression model.Kaplan-Meier survival curve showed that the prognosis of the group with positive lymph node ratio≤0.07 was significantly better than that of the group with positive lymph node ratio>0.07(P<0.05).Conclusion The ratio of positive lymph nodes>0.07 is an independent risk factor for the prognosis of patients with M0 stage non-small cell lung cancer.

Positive lymph node ratioNon-small cell lung cancerM0 stageSEER databasePrognosis

魏荣、董娇、周佳

展开 >

重庆市南岸区中西医结合医院呼吸内科,重庆 400064

重庆市医药科技学校,重庆 400061

重庆医科大学附属第一医院呼吸与危重症医学科,重庆 400016

阳性淋巴结比率 非小细胞肺癌 M0期 SEER数据库 预后

2025

贵州医药
贵州省医药卫生学会办公室

贵州医药

影响因子:0.493
ISSN:1000-744X
年,卷(期):2025.49(1)